Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Simon Property Group Inc (SPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Simon Property Group Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while Simon Property Group Inc trades at $201.9 (market cap $64.29B). The key difference: Simon Property Group Inc is far larger — about 16× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Simon Property Group Inc pays a 4.48% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Simon Property Group Inc for 100 Days on average.
| INDV | SPG | |
|---|---|---|
Market Cap | $4.03B | $64.29B |
Volume | 2,781,171 | 1,236,199 |
Sector | Health | Real Estate |
52-Week High | $41.83 | $236.70 |
52-Week Low | $24.09 | $173.35 |
Typical Hold Time | 0 Days | 100 Days |
Enterprise Value | $4.32B | $92.74B |
Dividend Yield | — | 4.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Simon Property Group (SPG) trades at $200.65, down 0.38% on the day, with mixed technical signals showing bearish moving averages but neutral oscillators. The REIT maintains strong fundamentals with a 72.7% net income margin and 135.7% ROE in 2025, though recent Q2 2026 earnings missed expectations. Positive developments include strong leasing demand, a new media network launch, and insider buying activity, while facing headwinds from rising bond yields and $2B in 2024 debt maturities.
SPG presents a compelling value opportunity with a 14.02 P/E ratio and 42% analyst buy ratings, supported by a $218.45 consensus price target representing 9% upside. However, investors face risks from interest rate sensitivity, negative cash flow trends, and high leverage with $24.21B long-term debt. The stock's outlook balances strong operational performance against macroeconomic pressures in the REIT sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →
